Most extra IVF treatments lack evidence, may be costly waste, study finds

A comprehensive study has revealed that the majority of additional In Vitro Fertilization (IVF) treatments offered to individuals seeking to enhance their chances of conception are not supported by credible evidence. These supplementary options, which have seen a surge in availability, often fail to improve fertility and may represent a significant financial burden for patients.

These add-on procedures, medications, or techniques are increasingly being marketed to patients undergoing standard IVF treatment. While proponents claim they can boost success rates, the largest study of its kind indicates a lack of robust scientific backing for these claims. Patients are often presented with these options with the promise of increased likelihood of achieving pregnancy.

The research suggests that these extra interventions may not only be ineffective but could also lead to unnecessary costs for individuals and couples undergoing fertility treatments. The findings raise concerns about the marketing and evidence base for certain ancillary services within the IVF industry, urging a more critical evaluation by patients and healthcare providers alike.